GGrantIndex
Sort

51,593 grants matching hepatitis

Regulation of Cholesterol Metabolism by Sestrin1

$388,438
Brian Wesley Parks · University Of Wisconsin-Madison · R01 · FY2021 · HL

Immune Responses to Capsid in AAV-Mediated Gene Transfer

$388,391
Katherine A High · Wistar Institute · P01 · FY2010 · HL

Novel liver fibrosis test for early detection and classification

$388,354
Ramila Philip · Immunotope, Inc. · R41 · FY2013 · AA

The Role of Hepatocyte ABCA1 in Lipid Mobilization and Transport

$388,334
John S Parks · Wake Forest University Health Sciences · R01 · FY2017 · HL

The Role of Hepatocyte ABCA1 in Lipid Mobilization and Transport

$388,334
John S Parks · Wake Forest University Health Sciences · R01 · FY2016 · HL

Role of Eosinophils in Hepatic Ischemia Reperfusion Injury

$388,331
Cynthia Ju · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · DK

Role of Eosinophils in Hepatic Ischemia Reperfusion Injury

$388,331
Cynthia Ju · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · DK

Ultrasound Guidance for a Laparoscopic Surgical Robot

$388,329
Russell H Taylor · Intuitive Surgical, Inc. · R42 · FY2006 · RR

Cholesterol Metabolizing P450s; structure and function

$388,325
Irina A Pikuleva · Case Western Reserve University · R01 · FY2016 · GM

Cholesterol Metabolizing P450s; structure and function

$388,325
Irina A Pikuleva · Case Western Reserve University · R01 · FY2019 · GM

Cholesterol Metabolizing P450s; structure and function

$388,325
Irina A Pikuleva · Case Western Reserve University · R01 · FY2017 · GM

APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis

$388,300
Jenny E. Kanter · University Of Washington · R01 · FY2023 · DK

APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis

$388,300
Jenny E. Kanter · University Of Washington · R01 · FY2022 · DK

APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis

$388,300
Jenny E. Kanter · University Of Washington · R01 · FY2021 · DK

APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis

$388,300
Jenny E. Kanter · University Of Washington · R01 · FY2020 · DK

Transplantation Assay for Liver Repopulating Cells

$388,280
Markus Grompe · Oregon Health & Science University · R01 · FY2014 · DK

Transplantation Assay for Liver Repopulating Cells

$388,280
Markus Grompe · Oregon Health & Science University · R01 · FY2015 · DK

Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis

$388,218
Karin E. Bornfeldt · University Of Washington · P01 · FY2020 · HL

HBV dipstick for resource-limited blood banks

$388,206
Diagnostics For The Real World, Ltd · R44 · FY2004 · HL

Epigenetic regulation of metabolism by target of rapamycin complex 2

$388,170
Alexander A Soukas · Massachusetts General Hospital · R01 · FY2016 · DK

Epigenetic regulation of metabolism by target of rapamycin complex 2

$388,170
Alexander A Soukas · Massachusetts General Hospital · R01 · FY2014 · DK

Epigenetic regulation of metabolism by target of rapamycin complex 2

$388,170
Alexander A Soukas · Massachusetts General Hospital · R01 · FY2015 · DK

Epigenetic regulation of metabolism by target of rapamycin complex 2

$388,170
Alexander A Soukas · Massachusetts General Hospital · R01 · FY2017 · DK

HCV, Alcohol and Host Defense

$388,159
Gyongyi Szabo · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · AA

ROLE OF DGAT IN TRIACYLGLYCEROL METABOLISM

$388,158
J. David Gladstone Institutes · R01 · FY2002 · DK